The global emerging sleep apnea devices and platforms market is projected to reach up to $ 13,179.6 million by 2030, witnessing a compound annual growth rate (CAGR) of 9.94% during the forecast period 2021-2030.
The global emerging sleep apnea devices and platforms market is highly consolidated in nature. The market is pre-dominated by major medical device companies, such as ResMed, Koninklijke Philips N.V., and Fisher and Paykel Healthcare Limited.
North America dominated the global emerging sleep apnea devices and platforms market with a market share of 43.56% in 2019. The region is anticipated to reach up to $5,227.2 million by 2030, with a CAGR of 8.99% for the forecast period 2021-2030.
During COVID-19 pandemic, various regulatory agencies such as Food and Drug Administration (FDA), U.S. and Therapeutic Goods Administration (TGA) have approved the usage of positive airway pressure (PAP) devices such as continuous positive airway pressure (CPAP) devices, bilevel positive airway pressure (BPAP) devices, and adaptive servo ventilators (ASVs) as ventilators. Additionally, the demand for oral appliances has also increased significantly due to the high risk of infection in the case of COVID-19 positive sleep apnea patients. In the situation, the usage of a PAP device can increase the risk of infection for the patient’s peers. Other devices with increased demand included home sleep testing devices and sleep apnea screening and monitoring devices and solutions. In addition to conventional devices, emerging therapeutic and diagnostic and monitoring devices have also witnessed a significant increase in demand.
Key Questions Answered in this Report:
• How has the COVID-19 pandemic impacted the global emerging sleep apnea devices and platforms market?
• Is the usage of continuous positive airway pressure (CPAP) devices, bilevel positive airway pressure (BPAP) devices, and adaptive servo-ventilators (ASV) as clinical ventilators a sustainable solution for the post-COVID-19 scenario?
• How can the market cater to global healthcare system requirements such as remote patient monitoring, constant collection of clinical data, and clinical data management and its analysis?
• What is the global regulatory landscape pertaining to the global emerging sleep apnea devices and platforms market? How have the regulations altered owing to the COVID-19 pandemic?
• What has been the patent landscape for the market during 2017-2020? How has the COVID-19 pandemic impacted the patent scenario?
• What are the major companies operating in the market and their respective market share?
• What are the major strategies employed by the companies to enter the market or for business expansion?
• How are the emerging sleep apnea devices and platforms different from conventional sleep apnea devices?
• What are the pipeline products and their analysis for the market?
• What are the major industry trends, market drivers, and market restraints that would impact the market during the forecast period 2021-2030? What are the growth opportunities for the market?
• What therapeutic and diagnostic devices and platforms are expected to witness the highest growth during the forecast period 2021-2030?
• Which end-user segment is expected to lead the market during the forecast period 2021-2030?
• What would be the country-level revenue share and CAGR for the market during the forecast period 2021-2030?
• Which emerging countries have immense opportunities for the growth and adoption of sleep apnea devices and platforms? Would the scenario continue for the next five years?
• Where will the advancements in technology offered by various companies take the industry in the mid to long term?
• What are the upcoming alternative therapies and associated devices for sleep apnea treatment?
For more information on this report (along with the option to Get a Free sample)
Visit - Emerging Sleep Apnea Devices and Platforms Market- Analysis & Forecast | BIS Research
No comments:
Post a Comment